Humanwell healthcare (600079.SH) announced that the subsidiary's application for the market approval of recombinant plasmid - Hepatocyte Growth Factor injection has been accepted.

Humanwell Healthcare (600079.SH) announced that its holding subsidiary Wuhan Guogu Humanwell Biomedical Co., Ltd....

Zhitong FinanceDec 4 03:50 ET

Sinolink Securities: "Spring excitement" may surpass expectations, focusing on the ultimate technology theme.

It is expected that the domestic 'easy mmf + loose fiscal policy' will usher in signs of marginal improvement from the macro, meso to micro levels.

Zhitong FinanceDec 1 17:36 ET

Humanwell Healthcare (600079.SH): The major shareholder has signed a voting rights entrustment agreement.

On November 29, Gelonghui reported that humanwell healthcare (600079.SH) announced further support for the company's healthy development, to maintain operational stability, and promote sustainable development. On November 29, 2024, Yichang Investment Group signed the "Voting Rights Entrustment Agreement" and the "Supplementary Agreement to the Voting Rights Entrustment Agreement" with Li Jie, Chen Xiaoqing, and Xu Huabin. Li Jie, Chen Xiaoqing, and Xu Huabin will hold 141,768,007 shares of the company (accounting for 8.69% of the total share capital of the company, including 86,747,204 shares held by Mr. Li Jie and 43,000 shares held by Mr. Chen Xiaoqing.)

Gelonghui FinanceNov 29 05:27 ET

Humanwell Healthcare Registers Endometriosis Drug With State Administrator

MT NewswiresNov 28 23:09 ET

Humanwell Healthcare Unit's Three Nervous System Drugs Included in China's 2024 Drug Insurance Catalog

MT NewswiresNov 28 22:32 ET

humanwell healthcare (600079.SH): The company's pharmaceutical products are included in the national medical insurance catalog.

On November 28, Gelonghui reported that humanwell healthcare (600079.SH) announced that its holding subsidiary Yichang humanwell pharmaceutical Co., Ltd. (referred to as "Yichang humanwell", in which the company holds 80% of the shares) has had its products, injectable phosphopropofol disodium, hydromorphone hydrochloride sustained-release tablets, and clonazepam tablets, included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Pharmaceutical Catalog (2024)" through negotiations.

Gelonghui FinanceNov 28 03:32 ET